CN Patent

CN103408546A — 2-苯氨基嘌呤类plk1抑制剂及其用途

Assigned to China Pharmaceutical University · Expires 2013-11-27 · 12y expired

What this patent protects

本发明涉及药物化学领域，具体涉及一类2-苯氨基嘌呤化合物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为Polo样激酶1抑制剂的用途。

USPTO Abstract

本发明涉及药物化学领域，具体涉及一类2-苯氨基嘌呤化合物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为Polo样激酶1抑制剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103408546A
Jurisdiction
CN
Classification
—
Expires
2013-11-27
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.